Summit Securities Group’s Clover Health Investments CLOV Stock Holding History

Summit Securities Group’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$15.5K	Buy	+3,586	New	+$16.1K	﹤0.01%	753

Other funds holding CLOV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return

Summit Securities Group's CLOV Position: Q3 2026 in Review

Summit Securities Group opened a new position in Clover Health Investments (CLOV) in Q3 2026: 3,586 shares worth $15.5K. The stake represents ﹤0.01% of the portfolio and ranks #753 among its holdings.

118 funds tracked by Wall St. Rank hold CLOV as of Q3 2026.

Summit Securities Group held 3,586 shares of Clover Health Investments worth $15.5K as of Q3 2026.
Clover Health Investments was a new Summit Securities Group position in Q3 2026.
Clover Health Investments made up ﹤0.01% of Summit Securities Group's portfolio in Q3 2026, its #753 holding.
118 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2026.

Based on Summit Securities Group's 13F filing for Q3 2026, filed 5 Nov 2026.